URGN UroGen Pharma Ltd.
Healthcare · Pharmaceutical Preparations · Market cap: $1.3B
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $508.8K |
| 2022-Q2 | $0 | $1.7K |
| 2022-Q3 | $0 | $28.0K |
| 2022-Q4 | $0 | $3.1K |
| 2023-Q1 | $0 | $35.8K |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $68.4K |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $445.4K |
| 2024-Q2 | $0 | $67.4K |
| 2024-Q3 | $0 | $31.1K |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $111.8K |
| 2025-Q2 | $0 | $38.0K |
| 2025-Q3 | $0 | $465.1K |
| 2025-Q4 | $0 | $287.1K |
| 2026-Q1 | $0 | $292.4K |
| 2026-Q2 | $0 | $792.7K |
| 2026-Q3 | $0 | $3.4M |
| 2026-Q4 | $0 | $80.8K |
Bought$2.1K1 buy day
Sold$6.7M43 sell days
Net insider flow-$6.7Mnet selling · 5 years
Latest trade2026-10-08Degnan Chris
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-10-08 | Sell | Degnan Chris | CFO | 2,202 | $36.69 | $80.8K | 1 |
| 2026-09-08 | Sell | Smith Jason Drew | General counsel | 1,519 | $42.54 | $64.6K | 1 |
| 2026-09-08 | Sell | Schoenberg Mark | Other C-suite | 871 | $42.92 | $37.4K | 1 |
| 2026-08-20 | Sell | Schoenberg Mark | Other C-suite | 60,677 | $47.05 | $2.9M | 1 |
| 2026-07-09 | Sell | Schoenberg Mark | Other C-suite | 10,000 | $40.00 | $400.0K | 1 |
| 2026-06-22 | Sell | Schoenberg Mark | Other C-suite | 10,000 | $35.01 | $350.1K | 1 |
| 2026-06-08 | Sell | Schoenberg Mark | Other C-suite | 5,222 | $27.30 | $142.6K | 1 |
| 2026-05-08 | Sell | Schoenberg Mark | Other C-suite | 10,000 | $30.00 | $300.0K | 1 |
| 2026-02-03 | Sell | Smith Jason Drew | General counsel | 7,479 | $19.69 | $147.3K | 3 |
| 2026-02-03 | Sell | Schoenberg Mark | Other C-suite | 7,373 | $19.69 | $145.2K | 3 |
| 2025-11-19 | Sell | Schoenberg Mark | Other C-suite | 10,000 | $25.00 | $250.0K | 1 |
| 2025-10-08 | Sell | Degnan Chris | CFO | 2,203 | $16.85 | $37.1K | 1 |
| 2025-09-08 | Sell | Smith Jason Drew | General counsel | 1,520 | $19.11 | $29.0K | 1 |
| 2025-09-08 | Sell | Schoenberg Mark | Other C-suite | 871 | $19.11 | $16.6K | 1 |
| 2025-08-11 | Sell | Schoenberg Mark | Other C-suite | 10,000 | $17.69 | $176.9K | 1 |
| 2025-07-28 | Sell | Smith Jason Drew | General counsel | 7,522 | $19.14 | $144.0K | 1 |
| 2025-07-28 | Sell | Schoenberg Mark | Other C-suite | 5,149 | $19.14 | $98.6K | 1 |
| 2025-06-09 | Sell | Schoenberg Mark | Other C-suite | 5,162 | $7.37 | $38.0K | 1 |
| 2025-01-31 | Sell | Smith Jason Drew | General counsel | 7,379 | $11.14 | $82.2K | 3 |
| 2025-01-31 | Sell | Schoenberg Mark | Other C-suite | 2,655 | $11.14 | $29.6K | 2 |
| 2024-09-09 | Sell | Smith Jason Drew | General counsel | 1,521 | $13.08 | $19.9K | 1 |
| 2024-09-09 | Sell | Schoenberg Mark | Other C-suite | 859 | $13.08 | $11.2K | 1 |
| 2024-06-10 | Sell | Schoenberg Mark | Other C-suite | 5,153 | $13.08 | $67.4K | 1 |
| 2024-03-18 | Sell | Schoenberg Mark | Other C-suite | 12,000 | $14.05 | $168.6K | 1 |
| 2024-02-01 | Sell | Smith Jason Drew | General counsel | 4,993 | $15.78 | $78.8K | 3 |
| 2024-02-01 | Sell | Schoenberg Mark | Other C-suite | 3,789 | $15.78 | $59.8K | 3 |
| 2024-01-31 | Sell | Smith Jason Drew | General counsel | 4,993 | $15.74 | $78.6K | 3 |
| 2024-01-31 | Sell | Schoenberg Mark | Other C-suite | 3,789 | $15.74 | $59.6K | 3 |
| 2023-08-31 | Sell | Smith Jason Drew | General counsel | 3,800 | $18.01 | $68.4K | 1 |
| 2023-01-31 | Sell | Schoenberg Mark | Other C-suite | 1,900 | $10.12 | $19.2K | 3 |
| 2023-01-31 | Sell | Smith Jason Drew | General counsel | 1,636 | $10.12 | $16.6K | 2 |
| 2022-10-31 | Sell | Schoenberg Mark | Other C-suite | 258 | $11.85 | $3.1K | 1 |
| 2022-08-31 | Sell | Smith Jason Drew | General counsel | 3,606 | $7.21 | $26.0K | 1 |
| 2022-08-01 | Sell | Schoenberg Mark | Other C-suite | 259 | $7.81 | $2.0K | 1 |
| 2022-04-30 | Sell | Schoenberg Mark | Other C-suite | 254 | $6.62 | $1.7K | 1 |
| 2022-01-31 | Sell | Barrett Elizabeth A. | CEO | 8,195 | $7.58 | $62.1K | 2 |
| 2022-01-31 | Sell | Schoenberg Mark | Other C-suite | 1,374 | $7.58 | $10.4K | 2 |
| 2022-01-31 | Sell | Smith Jason Drew | General counsel | 414 | $7.58 | $3.1K | 1 |
| 2022-01-31 | Sell | Henderson Molly | CFO | 331 | $7.58 | $2.5K | 1 |
| 2022-01-26 | Sell | Schoenberg Mark | Other C-suite | 111 | $8.09 | $898 | 1 |
| 2022-01-04 | Sell | Barrett Elizabeth A. | CEO | 46,968 | $9.15 | $429.8K | 1 |
| 2021-11-30 | Sell | Smith Jason Drew | General counsel | 3,803 | $12.03 | $45.8K | 1 |
| 2021-11-30 | Sell | Henderson Molly | CFO | 2,587 | $12.03 | $31.1K | 1 |
| 2021-11-18 | Buy | Schoenberg Mark | Other C-suite | 160 | $13.10 | $2.1K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Schoenberg Mark | Other C-suite | $2.1K | $5.2M | 2026-09-08 |
| Smith Jason Drew | General counsel | $0 | $804.3K | 2026-09-08 |
| Barrett Elizabeth A. | CEO | $0 | $491.9K | 2022-01-31 |
| Degnan Chris | CFO | $0 | $117.9K | 2026-10-08 |
| Henderson Molly | CFO | $0 | $33.6K | 2022-01-31 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.